SYSTEMIC LUPUS ERTHEMATOSUS
Clinical trials for SYSTEMIC LUPUS ERTHEMATOSUS explained in plain language.
Never miss a new study
Get alerted when new SYSTEMIC LUPUS ERTHEMATOSUS trials appear
Sign up with your email to follow new studies for SYSTEMIC LUPUS ERTHEMATOSUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New lupus drug trial hopes to tame the immune system
Disease control Recruiting nowThis study tests a new medicine called GR1803 in people with systemic lupus erythematosus (SLE), an autoimmune disease where the body attacks itself. The goal is to see if the drug is safe and can help control the disease. About 44 adults with active lupus who are already on stan…
Matched conditions: SYSTEMIC LUPUS ERTHEMATOSUS
Phase: PHASE1, PHASE2 • Sponsor: Genrix (Shanghai) Biopharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 10, 2026 13:24 UTC
-
Could umbilical cord stem cells tame lupus? new trial launches
Disease control Recruiting nowThis early-stage study tests a single injection of stem cells from donated umbilical cords in 10 adults with active lupus. The goal is to see if the treatment is safe and can improve kidney function and reduce disease activity. Participants continue their usual medications and ar…
Matched conditions: SYSTEMIC LUPUS ERTHEMATOSUS
Phase: PHASE1 • Sponsor: LiveKidney.Bio • Aim: Disease control
Last updated Jun 05, 2026 12:06 UTC
-
Immune cell therapy trial aims to tame childhood autoimmune diseases
Disease control Recruiting nowThis early-stage study tests a new treatment using specially engineered immune cells (CAR-NK cells) in 36 children with B cell-related autoimmune diseases like lupus and IgA nephropathy. The goal is to see if the therapy is safe and can control disease activity. Participants rece…
Matched conditions: SYSTEMIC LUPUS ERTHEMATOSUS
Phase: EARLY_PHASE1 • Sponsor: The Children's Hospital of Zhejiang University School of Medicine • Aim: Disease control
Last updated Jun 05, 2026 12:05 UTC
-
Can vaccine timing boost protection for the vulnerable?
Prevention Recruiting nowThis study looks at the best way to give COVID-19 booster and flu vaccines to people with weakened immune systems, such as those with rheumatoid arthritis, HIV, or organ transplants. It compares giving both vaccines at the same time versus one month apart, and also tests if getti…
Matched conditions: SYSTEMIC LUPUS ERTHEMATOSUS
Phase: PHASE2 • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Prevention
Last updated Jun 12, 2026 12:07 UTC
-
Fatigue mystery: scientists seek to classify its many forms
Knowledge-focused Recruiting nowThis study aims to understand the different types of fatigue people experience, especially those with conditions like cancer, lupus, and chronic fatigue syndrome. Researchers will compare fatigued and non-fatigued adults using interviews, questionnaires, physical tests, and optio…
Matched conditions: SYSTEMIC LUPUS ERTHEMATOSUS
Sponsor: National Center for Complementary and Integrative Health (NCCIH) • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:06 UTC